Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Dunbar

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetes Forecast|December 31, 2014
Food for a dayStephanie Dunbar
Diabetes Forecast|October 26, 2013
Truth in advertisingMadelyn L Wheeler, Stephanie Dunbar
Current Pain and Headache Reports|August 8, 2019
Tramadol Prescription over a 4-Year Period in the USALuisa M Bigal, Kristen Bibeau, Stephanie Dunbar
Biometrics|September 2, 2004
Designs for single- or multiple-agent phase I trialsMark R Conaway, Stephanie Dunbar, Shyamal D Peddada
American Journal of Botany|June 3, 2011
Molecular phylogeny and adaptive radiation of the endemic Hawaiian Plantago species (Plantaginaceae)Stephanie Dunbar-Co, Ania M Wieczorek, Clifford W Morden
The Australian Journal of Rural Health|February 6, 2019
'The public rely on me a lot': Rural pharmacists' perspectives on their roles in oral health careHa Hoang, Tony Barnett, Mark Kirschbaum, et al.
Advances in Therapy|February 17, 2009
Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonistAndrew E Denker, Gaetano Morelli, Laura K Vessey, et al.
Journal of Clinical Pharmacology|October 22, 2008
Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokineticsJules I Schwartz, Stephanie Dunbar, Jinyu Yuan, et al.
Journal of Clinical Psychopharmacology|June 23, 2012
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug usersKerri A Schoedel, Carol Addy, Bijan Chakraborty, et al.
Advances in Therapy|November 8, 2008
Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarinJules I Schwartz, Stephanie Dunbar, Jinyu Yuan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetes Forecast|December 31, 2014
Food for a dayStephanie Dunbar
Diabetes Forecast|October 26, 2013
Truth in advertisingMadelyn L Wheeler, Stephanie Dunbar
Current Pain and Headache Reports|August 8, 2019
Tramadol Prescription over a 4-Year Period in the USALuisa M Bigal, Kristen Bibeau, Stephanie Dunbar
Biometrics|September 2, 2004
Designs for single- or multiple-agent phase I trialsMark R Conaway, Stephanie Dunbar, Shyamal D Peddada
American Journal of Botany|June 3, 2011
Molecular phylogeny and adaptive radiation of the endemic Hawaiian Plantago species (Plantaginaceae)Stephanie Dunbar-Co, Ania M Wieczorek, Clifford W Morden
The Australian Journal of Rural Health|February 6, 2019
'The public rely on me a lot': Rural pharmacists' perspectives on their roles in oral health careHa Hoang, Tony Barnett, Mark Kirschbaum, et al.
Advances in Therapy|February 17, 2009
Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonistAndrew E Denker, Gaetano Morelli, Laura K Vessey, et al.
Journal of Clinical Pharmacology|October 22, 2008
Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokineticsJules I Schwartz, Stephanie Dunbar, Jinyu Yuan, et al.
Journal of Clinical Psychopharmacology|June 23, 2012
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug usersKerri A Schoedel, Carol Addy, Bijan Chakraborty, et al.
Advances in Therapy|November 8, 2008
Influence of taranabant, a cannabinoid-1 receptor inverse agonist, on pharmacokinetics and pharmacodynamics of warfarinJules I Schwartz, Stephanie Dunbar, Jinyu Yuan, et al.
Pageof 2